Currently, IL-15 antagonizing antibodies (e.g., AMG 714) have demonstrated efficacy in treating autoimmune diseases such as celiac disease and ankylosing spondylitis (22), supporting their potential application in vitiligo. This evidence concerns the gene IL15 and vitiligo.